Identification of differentially expressed genes in rat aortic allograft vasculopathy.

No abstract is available for this paper.

• Publication year

  1996

• Venue

  American Journal of Pathology

• Publication date

  1996-08-01

• Fields of study

  Biology, Medicine

• Identifiers
  PMID 8701998PMCID PMC1865292
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Ferritin protects endothelial cells from oxidized low density lipoprotein in vitro.

  1995cited by this paper
• Reciprocal regulation of endothelin-1 and endothelial constitutive NOS in proliferating endothelial cells.

  1995cited by this paper
• mRNA decay mediated by two distinct AU-rich elements from c-fos and granulocyte-macrophage colony-stimulating factor transcripts: different deadenylation kinetics and uncoupling from translation

  1995cited by this paper
• Intrathymic tolerance in the Lewis-to-F344 chronic cardiac allograft rejection model.

  1995cited by this paper
• INHIBITION OF TRANSPLANT ARTERIOSCLEROSIS IN RAT AORTIC GRAFTS BY LOW MOLECULAR WEIGHT HEPARIN DERIVATIVES

  1995cited by this paper
• B-cell development in mouse and man

  1995cited by this paper
• Nitric oxide synthase induction and chronic cardiac allograft rejection.

  1995cited by this paper
• Intragraft expression of IL-10 messenger RNA: a novel correlate of renal allograft rejection.

  1995cited by this paper
• Treatment with rapamycin and mycophenolic acid reduces arterial intimal thickening produced by mechanical injury and allows endothelial replacement.

  1995cited by this paper
• Recent advances in differential display.

  1995cited by this paper
• Inhibition of cellular ras prevents smooth muscle cell proliferation after vascular injury in vivo

  1995cited by this paper
• Upregulation and modulation of inducible nitric oxide synthase in rat cardiac allografts with chronic rejection and transplant arteriosclerosis.

  1995cited by this paper
• Stabile D‐peptide analog of insulin‐like growth factor‐l inhibits smooth muscle cell proliferation after carotid ballooning injury in the rat

  1995cited by this paper
• Isoprenoids and Ras: potential role in chronic rejection.

  1995cited by this paper
• Sequential cytokine dynamics in chronic rejection of rat renal allografts: roles for cytokines RANTES and MCP-1.

  1995cited by this paper
• Use of differential display to identify differentially expressed mRNAs induced by rat carotid artery balloon angioplasty.

  1995cited by this paper
• Effect of nitric oxide on expression of transferrin receptor and ferritin and on cellular iron metabolism in K562 human erythroleukemia cells.

  1995cited by this paper
• Acute rejection accelerates graft coronary disease in transplanted rabbit hearts.

  1995cited by this paper
• Pathology and etiology of chronic rejection of the heart

  1994cited by this paper
• Inhibition of rab5 GTPase activity stimulates membrane fusion in endocytosis.

  1994cited by this paper
• Coronary atherosclerosis in transplanted mouse hearts. II. Importance of humoral immunity.

  1994cited by this paper
• Chronic cardiac rejection: identification of five upregulated genes in transplanted hearts by differential mRNA display.

  1994cited by this paper
• Inhibition of chronic vascular rejection in primate cardiac xenografts using mycophenolate mofetil.

  1994cited by this paper
• Effects of leflunomide and cyclosporine on aortic allograft chronic rejection in the rat.

  1994cited by this paper
• Insulin-like growth factor-I and platelet-derived growth factor-BB induce directed migration of human arterial smooth muscle cells via signaling pathways that are distinct from those of proliferation.

  1994cited by this paper
• Emerging concepts in the Ras superfamily of GTP‐binding proteins

  1993cited by this paper
• A first or dominant immunization. II. Induced immunoglobulin carries transforming growth factor beta and suppresses cytolytic T cell responses to unrelated alloantigens

  1993cited by this paper
• The pathogenesis of atherosclerosis: a perspective for the 1990s

  1993cited by this paper
• Distribution and cloning of eukaryotic mRNAs by means of differential display: refinements and optimization.

  1993cited by this paper
• Somatostatin analog Lanreotide inhibits myocyte replication and several growth factors in allograft arteriosclerosis

  1993cited by this paper
• Regulating the fate of mRNA: the control of cellular iron metabolism.

  1993cited by this paper
• An immunologist's look at the Rho and Rab GTP-binding proteins.

  1993cited by this paper
• Pathophysiology of vascular wall changes in chronic allograft rejection

  1993cited by this paper
• Differential display of eukaryotic messenger RNA by means of the polymerase chain reaction.

  1992cited by this paper
• Arbitrarily primed PCR fingerprinting of RNA.

  1992cited by this paper
• MACROPHAGE SUBPOPULATIONS IN NORMAL AND TRANSPLANTED HEART AND KIDNEY TISSUES IN THE RAT1,2

  1992cited by this paper
• A promoter element that exerts positive and negative control of the interleukin 2-responsive J-chain gene.

  1992cited by this paper
• Importance of plasma cells in the infiltrate of renal allografts. An immunohistochemical study.

  1991cited by this paper
• Increased ferritin gene expression is both promoted by cAMP and a marker of growth arrest in rabbit vascular smooth muscle cells.

  1991cited by this paper
• Translational control during the acute phase response. Ferritin synthesis in response to interleukin-1.

  1990cited by this paper
• Fingerprinting genomes using PCR with arbitrary primers.

  1990cited by this paper
• The frequency of B cells secreting antibodies against donor MHC antigens in rats rejecting renal allografts

  1990cited by this paper
• Immunology of atherosclerosis: cellular composition and major histocompatibility complex class II antigen expression in aortic intima, fatty streaks, and atherosclerotic plaques in young and aged human specimens.

  1990cited by this paper
• Cardiac transplantation in the rat. II. Alteration of the severity of donor graft arteriosclerosis by modulation of the host immune response.

  1990cited by this paper
• Structural and functional properties of ras proteins

  1989cited by this paper
• Cardiac transplantation in the rat. I. The effect of histocompatibility differences on graft arteriosclerosis.

  1989cited by this paper
• Induction of ferritin subunit synthesis by iron is regulated at both the transcriptional and translational levels.

  1988cited by this paper
• Ferritin synthesis in differentiating Friend erythroleukemic cells.

  1987cited by this paper
• Immunoglobulin J chain gene from the mouse.

  1986cited by this paper
• Structure and expression of ferritin genes in a human promyelocytic cell line that differentiates in vitro

  1986cited by this paper
• Isolation of biologically active ribonucleic acid from sources enriched in ribonuclease.

  1979cited by this paper
• [IRON METABOLISM].

  1964cited by this paper

• The current status and future directions of myxoma virus, a master in immune evasion

  2011cites this paper
• Chapter 2 – Immunology of Graft Rejection

  2008cites this paper
• Study on differential development gene of Pholiota adiposa bv DDRT-PCR

  2007cites this paper
• Microarray-based gene expression profiling of retransplanted rat cardiac allografts that develop cardiac allograft vasculopathy.

  2005cites this paper
• PATHOGENETIC FEATURES OF PROTEINURIA STUDIES ON CONGENITAL NEPHROTIC SYNDROME OF THE FINNISH TYPE

  2002cites this paper
• Modern Immunosuppressives

  2001cites this paper
• A highly selective inhibitor of Rho-associated coiled-coil forming protein kinase, Y-27632, prolongs cardiac allograft survival of the BALB/c-to-C3H/He mouse model.

  2001cites this paper
• New targets for the prevention of transplant vascular disease.

  2001cites this paper
• Immunobiology of Chronic Cardiac Allograft Rejection

  2001cites this paper
• Mechanisms and Treatment Options of Chronic Graft Dysfunction Experimental and Clinical Studies

  2001cites this paper
• Mechanisms and Treatment Options of Chronic Graft Dysfunction

  2001cites this paper
• Emerging therapeutic strategies for the prevention and treatment of chronic allograft rejection.

  2000cites this paper
• Calcium channel blockers and angiotensin-converting enzyme inhibitors in the prevention of graft vasculopathy.

  2000cites this paper
• Modulation of the proliferation and gene expression of vascular smooth muscle cells induced by lymphocyte culture supernatants(1).

  2000cites this paper
• Etiology and pathophysiology of chronic transplant dysfunction

  2000cites this paper
• Progression of renal damage in chronic rejection.

  2000cites this paper
• Antibodies and chronic organ graft rejection.

  1999cites this paper
• Eotaxin and capping protein in experimental vasculopathy.

  1998cites this paper
• Cellular and molecular mechanisms in transplant arteriosclerosis (Review).

  1998cites this paper
• Development of Graft Vascular Disease in Transplanted Aortic Segments in Mice

  1998cites this paper
• Polymerase chain reaction methods in immunology.

  1998cites this paper
• Immunological mechanism of chronic rejection

  1997cites this paper
• Immunobiology and pathology of chronic rejection.

  1997cites this paper
• Genes upregulated in ischemia-induced arteriosclerosis in rat aortic transplants.

  1997cites this paper
• The use of mRNA differential display for discovery of novel therapeutic targets in cardiovascular disease.

  1997cites this paper